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The scope of the present study can be outlined
briefly thus
PART I.
Clinical and Laboratory Study of Scarlet Fever.
SECTION I. deals with the therapeutic value of antiscarlatinal 
serum.
SECTION II treats of certain serological aspects of the 
specific serum.
SECTION III is devoted to an inquiry into various aspects 
of the leucocytosis in scarlet fever, 
particularly in its relationship to serum 
treatment and to complications.
SECTION IV is occupied by a general summary and comment.
REFERENCES.
THE APPENDIX contains detailed results omitted from the 
main text as unnecessarily complicated but 
included here for reference and verification 
of statements made in previous sections.
PART II.
Observations on the Sedimentation Rate of the 
Red Blood Corpuscles in several acute and 
Chronic Infective Diseases.
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PART I.
Section I.
1# The Evolution of the Serum Treatment of Scarlet Fever.
2. General Remarks on the Nature and Treatment of the
Patients in the Present Series.
3. Classification Adopted.
4. Clinical Features of the Several Groups.
5. Results of Serum Treatment
(a) General Clinical Improvement,
(b) Effect on Temperature and Pulse Rate,
(c) Influence of Serum on the Occurrence of
Complications.
6. Conclusions as to the Therapeutic Value of Antiscarlatinal
Serum.
4.
1. The Evolution of the Serum Treatment of
Scarlet Fever.
(25)
In 1895 Marmorek realised the frequent
presence of haemolytic streptococci in the throats
of patients suffering from scarlet fever and concluded
that these organisms played a part in the production
(26)
of the disease* He therefore immunised horses 
with polyvalent strains of haemolytic streptococci 
from the throats of severe cases of scarlet fever and 
produced an antistreptococcic serum, which he used
therapeutically. His results were disappointing and 
his serum was forgotten.
(28)
Eight years later Moser repeated Marmorek*s
work and attempted to improve on his technique. He
inoculated a horse with (a) living cultures of
haemolytic streptococci isolated from the blood of
fatal cases of malignant scarlet fever, and (b) the
broth in which these streptococci were grown. This
serum, tested clinically by Moser and Schick gave
promising results, especially in toxic cases. It
produced a rapid fall of temperature, an improvement in
the rate and quality of the pulse, and a rapid disappear-
(37)
:ance of the toxic manifestations. Schick believed 
that the serum acted like an antitoxin. Despdte this 
success, however, the serum was not generally used 
because of the difficulty in preserving it, its liability 
to produce serum disease, and the impossibility of 
determining its strength.
(36)
In 1905 Savchenko showed that Moser's serum
contained scarlet fever antitoxin and streptococcic
(46)
bacterial bodies and later, Zingler expressed the
opinion that Moser's serum was polyvalent, antibacterial,
and strongly antitoxic.
No further work of importance was done on
Scarle^/
(9) (44)
Scarlet fever until 1919 when Bliss, TUnnicliffe,
(18) (40) (14)
Gordon, Stevens, Dochez and Shermann and 
(13)
Dochez proved that the streptococcus beta haemolyticus
isolated from the throats of patients suffering from
scarlet fever was specific for the disease. Following
(11)
upon this discovery Dick and Dick in 1923 swabbed
the throat of a volunteer with this organism and thus
oroduced a mild attack of scarlet fever. In the following 
(10)
year they discovered that Berkefeld filtrates of 
media in which the beta streptococcus haemolyticus had been 
grown contained the scarlet fever toxin and they thereupon 
proceeded to produce an antitoxin by injecting horses 
with these filtrates.
(13)
In 1924 Dochez also produced a scarlatinal 
antistreptococcic serum. He injected horses subcutaneously 
with agar and subsequently introduced into the solidified 
agar living cultures of beta streptococcus haemolyticus, 
in the attempt to produce a serum which would be both
(8)
antitoxic and antibacterial. Blake, Trask and Lynch
have tested this serum clinically and their results
indicate that it may possess a therapeutic value.
Messrs Parke, Davis and Co. have produced an
antitoxin by injecting horses with living specific
haemolytic streptococci and with scarlet fever toxin.
They claim that their preparation is both antitoxic and
antibacterial and good therapeutic results have been
(16)
obtained with it by Ferry, Pryer and Fisher . It 
is this serum which has been used in the treatment of the 
oases of scarlet fever in the present series.
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2. General Remarks on the Nature and Treatment of 
the patients In the Present Series.
The one hundred and sixteen cases of scarlet fever 
considered in this report were treated in the City of 
Glasgow Fever Hospital, Ruchill, between February, 1926 
and July, 1927. Doubtful cases, or cases with signs of 
any additional infection, were carefully excluded. 
Immediately after admission greffier*s medium was inoculated 
with the throat swab of each patient, incubated at 37°C. 
for twenty-four hours, at the expiry of which smears of 
the cultures were examined microscopically. This 
precaution precludes the chance inclusion of any atypical 
case of diphtheria. Only acutely ill patients were 
selected. The selection was based on the height of the 
temperature, the rapidity of the pulse, the condition of 
the throat, the brilliancy of the rash and the degree of 
prostration.
The patients came from all types of homes, and 
represented all grades in the social scale, their 
several occupations being correspondingly varied. The 
group included infants, school-children, apprentices, 
teachers, nurses, housewives and ’’unemployed”. The medical 
treatment after admission was essentially the same in all 
cases. Each was given a bath or blanket-bath, and then 
placed in bed in a pavilion ward, to which there was 
ample access of fresh air. If the temperature was 103°P 
or higher, tepid sponging was employed at four-hourly 
intervals until the temperature fell. In all cases 
a purgative was given. The throat was treated with 
gargles, or in more severe cases was syringed every 
four hours. The diet consisted of fluids until the 
temperature was noimal, when light diet and later full 
diet was allowed. Uncomplicated cases were allowed 
up/
up on the twenty-eighth day of illness and were dismissed 
on the forty-second day of illness. Complications of 
the same type were treated similarly, e.g. the treatment 
of nephritis included a blanket bed, heat, a diuretic 
mixture and a fluid diet. The only variable factor 
in the treatment was the administration of antitoxin 
or convalescent serum. The concentrated scarlet fever 
streptococcus antitoxin of Parke, Davis & Co. was used 
in all the eighty-four cases, which were treated with 
antitoxin. Some cases received 10 c.cms., others 
20-30 c.cms. of the antitoxin. Convalescent serum 
in doses of 6.5-8 c.cms. was used in three cases.
This serum was made by incubating the serum of scarlet 
fever patients obtained by vein puncture on the 3rd-4th 
week of illness at a temperature of 37®P. for fortyfive 
minutes on three successive days.
In every case the serum was given intramuscularly 
into the outer aspect of the thigh.
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3. Classification Adopted•
For purposes of comparison the one hundred and 
sixteen cases of scarlet fever were divided into six 
groups as shown in Table No.l, according to the type 
of case and the treatment given. It must be noted 
that the cases of Group II were more acuttly ill than 
the cases of Group I, as the regulations of the hospital 
required the administration of serum to acutely ill 
patients.
TABLE No. I.
Group. Disease. No. Treatment. No. of ^age
of cases cases
cases. which which
developed developed
complications. complications
I. Scarlet Fever 29 No antitoxin. 17 59%
II. ti I 68 10 c.cms.antitoxin. 36 55%
III. I I 10 20-30 c.cms. ” 6 ea%
IV. Toxic Scarlet 4 20 c.cms. ” 3 n5%
Fever.
V. Septic Scarlet 2 10 c.cms. " 1 50%
Fever. 1
VI. Scarlet Fever 3 6.5-8 c.cms. 2 67%
convalescent
—— - ——
serum.
-----
**
4. Clinical Features of the Several Groups. 
Clinical Features of Groups I and II.
The ages of the cases in Group I ranged from 3 - 5 2  
years; in Group II from 1 - 4 4  years. The average age 
in both groups was 11 years.
Previous Infection.
In each group the previous infections of the patients 
were, in order of frequency, measles, whooping cough, 
chickenpox and diphtheria.
Symptoms.
The commonest symptom in each group was sore 
throat, then sickness and vomiting, and lastly headache. 
State of Nutrition.
All the patients in Group I were well nourished;
96^ of the patients in Group II were well nourished.
Rash.
In Group I, 86^ and in Group II, 95^ of patients 
had faint to light generalised rashes.
In Group I, 10^ of cases had blotchy rashes over 
the extensor aspects of joints and in Group II, 5%. 
Glandular Involvement*
In Group I, 13^ of cases had greatly enlarged 
cervical glands and 43^ moderately enlarged glands; in 
Group II 6% of cases had greatly enlarged and 56^ 
moderately enlarged cervical glands.
Rhinitis•
In Group I, 21^ and in Group II 17^ of cases had 
serous or purulent rhinitis.
ThZ'oat.
In all cases the tonsils were moderately or greatly 
enlarged and spotted or covered with exudate.
Tongue.
The state of the tongue on admission was similar
in/
10.
in the two groups, when classified according to whether 
it was furred, furred and peeled, peeled or clean.
Heart and Lungs.
10^ of cases in Group I suffered from bronchitis on 
admission, and of cases in Group II.
9% of cases in Group II had a systolic apical murqiur, 
not conducted into the axilla, accompanying soft first 
heart sounds.
Minor Abnormalities.
In Group I one case was admitted on the eighth day of 
the puer per ium and in Group II one case vms admitted on the 
fifth day of the puerperium.
Three cases in Group II were admitted two days after 
sustaining a burn.
Temperature.
The maximum temperature in each group was 105°F.
In 16^ of cases in Group I the temperature exceeded 103®P during
acute phase.
" 35# " " II " " " " "
" " " I " " of 100-103°F "
” 65# ” ” II ” ” 100-103°F ”
Pulse Rate.
The maximum pulse rate in Group I was 156 per minute and 
in Group II 164 per minute.
In 20# of cases in Group I. the pulse rate exceeded 140 per min. 
” 61# ” ” II. ” ” ” ” ” ” ”
" B0% " " I .  " " " was 90-140 " "
” 20# ” ” II. ” ” ” ” ” " n
It is obvious in comparing the clinical cases in 
Groups I and II that these cases ere strictly comparable 
as regards age, previous infection, symptoms, state of 
nutrition, glandular involvement and presence of rhinitis, 
in the condition of throat, tongue, heart and lungs, and 
the presence of minor abnormalities. A comparison 
of/
11.
of temperature, pulse, rash and the estimation of the 
severity of the illness from clinical findings, shows 
that although these groups represent patients infected 
with the same type of scarlet fever, the cases in Group II 
were more severe than those of Group I. Therefore in 
treating the cases of Group II with 10 c.cms. scarlet 
fever stjteptococcus antitoxin, the efficacy of the serum 
is being put to a greater test than if applied to 
cases in Group I.
Clinical Features in Group III.
In Group III the ages ranged from 16-44 years and 
the average age was 16 years. The previous infections 
of the patients were measles, whooping-cough and 
chickenpox in order of frequency. A smaller proportion 
of patients in this group had suffered from these 
infections than in groups I and II.
Sore throat was the most common symptom, then 
sickness and vomiting, then headache. Sore throat 
was of greater frequency in this group than in Groups I 
and II and headache was a much less frequent symptom.
88# of patients were well nourished; the remainder were 
poorly nourished. All the patients were very acutely 
ill, and two showed signs of toxaemia. All had 
bright generalised rashes ; 50# of the patients had 
moderately enlarged cervical glands on admission and a 
similar number had purulent rhinitis. 42# of the 
patients had greatly enlarged tonsils, considerably 
spotted with exudate and the same number had moderately 
enlarged tonsils, slightly spotted. In 60# the tongue 
was furred and the remainder peeled on admission. Two 
thirds of the patients had soft feeble heart sounds at 
the apex. One patient suffered from nocturnal 
delirium/
12.
delirium. The maximum temperature during the acute
phase was 105°?. and the maximum pulse rate 170 per
minute. More than half of the patients had a
temperature exceeding 105°? and a pulse exceeding 140
per minute and less than half had a temperature of
100-103°?. and a pulse rate of 90 to 140 beats per minute.
The average residence in hospital was 58 days.
9 cases received 10 c.cms. antitoxin on the 2nd-5th day; of
illness,
1 ” ” 20 ” " ” ” 2nd day of illness.
This case died on the fifth day of illness.
8 cases received a second dose of 10 c.cms. antitoxin 1-3 days
after first dose.
1 case ” ” ” ” ” 20 ” antitoxin 1 day
after first dose.
Thus the cases in Group III were older, not so well
nourished and more acutely ill than the cases in Group I.
Clinical Features of Group IV.
All four patients suffered from toxic scarlet
fever and were very acutely ill. The ages of the cases
were 2, 3, 4 and 7 years. One case had previously 
suffered from measles and one from whooping cough. All 
the patients complained of sore throat and suffered from 
sickness and vomiting. None complained of headache.
Two suffered from cervical adenitis on admission. All 
the patients were well nourished. Two cases had no rash, 
while in hospital, and two had a faint rash with petechial 
haemorrhages on the trunk and extremities. Three cases 
had moderately enlarged cervical glands. One case had 
greatly enlarged tonsils covered with exudate, and three 
had moderately enlarged glands, patched with exudate. In 
each case the tonsils were ulcerated. All the patients 
had peeled tongues on admission. All had feeble heart 
sounds at the apex and a pulse of low tension. Three
cases suffered from bronchitis. All four patients were
delirious/
13.
delirious during the acute phase of the illness. The 
maximum temperature was 104.8°F and the maximum pulse 
rate 160 per minute. Two patients had a temperature above 
103^P. and two had a temperature of 100-103°?. The pulse 
rate in all cases exceeded 140 beats per minute in the 
acute phase. Three patients died after one, six and 
eleven days' residence in hospital respectively.
Clinical Features of Group V.
Both cases suffered from septic scarlet fever. The 
ages of the cases were 3 and 6 years. One gave a history 
of whooping-cough. Both suffered from sore throat, 
sickness, vomiting and headache. Both were well-nourished 
One appeared very acutely ill on admission, and one mildly 
ill. Both had bright generalised rashes, moderately 
enlarged tonsils, which were clean on admission. One had 
a furred and one a peeled tongue. In one case the heart 
sounds at the apex were soft and weak, and the pulse was of 
low tension. The maximum temperature was 104.4°F. and 
the maximum pulse rate 170 beats per minute. One 
patient died six days after admission.
Clinical Features of Group VI.
These differed in no wise from the clinical 
features of cases in Groups I and II. The only 
different factor was the treatment of cases in this 
group with 6.5-8 c.cms. convalescent serum.
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5. Results of Serum Treatment.
(a) General Clinical Improvement.
The most striking result of the administration of 
scarlet fever antitoxin in cases of scarlet fever during 
the first few days of illness is the rapid clinical 
improvement as shown by the disappearance of the signs and 
symptoms of toxaemia. A patient who, previous to 
treatment with antitoxin, is delirious, restless and 
sleepless, feels well in a few hours. Similarly a 
child who lies in bed dull, listless and disinterested 
will, a few hours after the administration of antitoxin, 
sit up, play with toys and demand food. Vomiting ceases, 
the throat becomes less painful, the cervical glands 
diminish, cyanosis disappears, the rash fades and moderate 
desquamation is followed by fine unobtrusive powdering.
With the fading of the rash there is usually six to twelve 
hours after the administration of serum a critical fall 
of temperature, from hyperpyrexia to a sub-febrile level, 
slowing of the pulse rate and an improvement in its tension. 
Graph No.lA shows this critical fall in temperature 
occurring within a few hours. In the subsequent tables 
showing the fall in temperature and pulse occurring in 
the first few days of illness in untreated and in treated 
cases, the temperature is considered raised until it 
remains at 97°P and the pulse is considered accelerated 
until it remains at (approx.) 76-80 beats per minute.
The respiration rate is correspondingly decreased. Indeed, 
within six to twelve hours the patient emerges from the
acute stage of the disease to the security of convalescence.
(6)
Birkhaug described similar results with Dochez»s serum
(33)
and Park also noted great improvement in the condition 
of the patients after treatment with Dochez*s serum and 
with serum which he made according to the Dochez method.
On/
15
On the other hand Graham is of opinion that therapeutic 
injections of serum gave little apparent relief. It is 
of interest that the results obtained in the present 
investigation with a commercial preparation of serum 
correspond closely with those obtained by Benson and
(4)
Maciver in their treatment of similar cases with 
the same serum.
Although the relief obtained by the patient after 
administration of antitoxin is the most marked clinical 
feature and should lead to the general practice of 
administration of serum to all suitable cases, nevertheless 
in our opinion scarlet fever antitoxin is not such a 
powerful weapon in the treatment of scarlet fever as is 
diphtheria antitoxin in the treatment of diphtheria.
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(b) Effect on Temperature and Pulse Rate.
(18)
Gordon states that the total febrile period in
days is shorter in patients receiving serum. Lindsay,
(23)
Rice and Selinger state that in their series of cases 
treated with antitoxin the average febrile period was 
7-6 days and in untreated cases the average number of 
days (not including rises of temperature due to later 
complications) was nine days. The results in the 
present series are in accord with this statement as will 
be seen from the accompanying table
TABLE No. 2.
Group. Treatment. Temp.Normal 
Average•
Pulse Kormal
Average.
I No antitoxin 5th day 8th day
II Antitoxin 2nd day 3rd day
III Antitoxin 3rd day 3rd day
Not only so but the following figures show clearly that 
provided the antitoxin is given during the first six days 
of illness, the same speedy return to normal is obtained 
irrespective of the actual date of administration.
TABLE No.3.
Day of illness on 
iifhich antitoxin was 
administered.
TEMPERATURE.
No. of days after administration of anti­
toxin in which temp fell to normal.
Group II. Group ÏÏÏ.
Minimum-maximum. Av. Minimum-maximum. Av.
1
i
2 days 2 days.
2 1-6 days. 2 ” 2 days. 2 days
3 1-10 ” 2 ” 2-4 " 2-5 "
4 1-5 " 2 ” 2-4 " 3 "
5
6 2 M 2 M 2-8 M . 5 "
Total average 2 days 3 days.
TABLE No. 4.
Day of illness on 
which antitoxin 
was administered.
PULSE.
No. of days after administration of 
antitoxin in which pulse rate fell to normal.
Group II. Group III.
Minimum-maximum. Av. M1 nimum-max imum. Av.
1 4 days 4 days.
2 2-6 ” 3 " 1 day. 1 day.
3 1-12 " 3 ” 3-7 days 4.5 ”
4 2-5 ” 3 ” 1-6 " 3.5 M
5
6 3 n 3 fi
Total average 3 days. Total average 3 days.
Tables Nos» 2 and 4 demonstrate that the pulse rate
becomes normal much more quickly in the acutely ill cases
of groups2 and 3, which were treated with antitoxin than
in the milder cases of group I, which did not receive antitoxin.
While return of temperature and pulse to normal occurred
earlier in the eases in the present series than in the
(25)
series of Lindsay, Rice and Selinger yet in both series 
the return of temperature and pulse to normal occurred 
earlier in the cases treated with antitoxin than in untreated 
cases.
When we recall in addition the disappearance of
toxaemic symptoms and the pronounced clinical improvement,
it is evident that the specific streptococcus antitoxin
is of definite value in the treatment of scarlet fever.
(10)
Gordon reports that the immediate result of 
injection of serum has frequently been a rise rather than 
a fall in temperature, possibly the result of foreign 
protein injected. This phenomenon was observed in the 
present series as is shown in the accompanying table;-
18.
Febrile Reaction after Serum. 
TABLE No. 5.
Group. Disease. Treatment. % cases 
showing the 
phenomenon.
Average Rise 
in temperature]
II Scarlet Fever 10 c.cms.antitoxin. 45% i.i°p.
: III If ft 20-30 " " 68% 0.75°F.
IV Toxic Scarlet 
Fever.
20 " " 60% 0.5°F.
V. Septic do. 10 " " 50% 0.2°F.
VI. Scarlet Fever Convalescent serum 0 0
ntrol 10 cases of 
Diphtheria.
Diphtheria
antitoxin.
, 100% 2.5°P.
In 53^ of the cases in this series a rise in temperature 
occurred immediately after the administration of antitoxin, 
the rise being most marked in mild cases and least marked 
in severe ones, i.e. in toxin and septic scarlet fever.
The rise in temperature occurred with greater frequency 
when 20-30 c.cms. antitoxin was given than when 10 c.ernes 
was given; although the actual rise in temperature was less 
after administration of 20 c.cms. than after 10 c.cms.
There was no rise in temperature after the administration 
of convalescent serum in doses of 6.5-8 c.cms.
In cases ofdiphtheria the rise in temperature after the 
administration of diphtheria antitoxin was greater than 
the rise in temperature in cases of scarlet fever after 
the administration of scarlet fever antitoxin and more­
over this rise occurred in every instance in the cases 
of diphtheria. These results would seem to indicate 
that the amount of foreign protein injected is an 
important factor in determining the frequency with 
which the elevation of temperature occurs. That the 
amount of foreign protein was not the only factor concerned 
is evidenced by the varying average rise in temperature 
in/
19.
in the different groups. Thus the maximum rise occurred 
in the mildest cases and the minimum rise In those which 
were most acutely ill, e.g. the patients with septic scarlet 
fever. It seems probable that this rise in temperature is 
a measure of the patientls power to react, and this is 
naturally greatest where the toxaemia is least severe.
(c) Influence of Serum on the Occurrence of Complications
V ^1)
Kinloch states that serum treatment of scarlet
fever is capable of reducing the serious complications of
(23)
the disease, while Lindsay, Rice and Selinger stress 
the early use of sufficient antitoxin in the reduction of
(33)
the incidence of complications of severe degree. Parke's
observations led him to conclude that while antitoxin has little
effect on complications, if they have already occurred, it
is of service in preventing their occurrence if given befofe
they have developed, probably due to the raising of
the resistance of the local tissues which prevents the
invasion of streptococci. The conclusions of Dick and 
(10)
Dick that the course of the disease is shortened
if antitoxin is given early and that the incidence of
complications and sequelae is greatly diminished is also
(41)
held by Therebe. The effect of antitoxin in
diminishing complications and alleviating the toxaemic
phase of scarlet fever is also described by Benson and 
(4) (19) (2)
Maciver, Gordon, and Anderson and Leonard, while 
(8)
Blake found serum effective in twenty complicated
(10)
cases treated before the fourth day. Dick and Dick 
have pointed out another use of serum in the removal of 
the toxic element of the disease which thus aids in 
the early recognition and treatment of complications 
which are already present. In fact the majority of 
workers have found that scarlet fever antitoxin 
produced/
20.
produced in various ways can prevent complications.
The results in the present series of cases is recorded 
to demonstrate that a commercial preparation of antitoxin 
possesses similar properties in this respect.
TABLE No. 6.
Grou rr l)isea8e. Treatment. iNo.of
cases which
No.of cases which developed 
one or more complications.
developed
complications .lor more ,2 or 
more,
3 or
more.
4 I
I Scarlet feveri,No antitoxin . 17/29=59^: 59% 28% 10% 7# I
II f « 10 c.cms. ” 36/68=53^ 53% 21% 6%
[II fi I 20-30 ” ” 6/10 = 60# 60% 30% 20% 10#
IV roxio " " 20 c.cms. " 3/4 = 75# 75% 50%
V Septic ” " 10 " " 1/2 = 50# 50% 50% 50%
VI Scarlet fever 6.5-8" "
convalescent
serum.
2/3 = 67# 50% 50% j
i
______ 1 1
Although the number of cases considered in this series 
is too small to enable general conclusions to be drawn, 
general tendencies may be noted, thus;-
The incidence of complications is greater in cases which 
are not treated with antitoxin than in cases treated with 
10 c.cms. antitoxin. Thus the numbers of cases 
developing one, two or three complications is greater in 
cases not treated with antitoxin than in cases treated with 
10 cms. antitoxin. 1% of cases not treated with antitoxin 
developed four complications; no cases treated with 10 
c.cms. antitoxin developed four complications. The number 
of cases in groups III, IV, V and VI is too small to
compare with Groups I and II.
(8)
Blake and Trask consider that septic processes 
may continue to advance although the patient has produced 
sufficient antitoxin to cure the specific toxaemia. They 
have found it impossible to demonstrate that scarlet 
fever/
21.
fever serum possesses any therapeutic value in post.
(6)
scarlatinal sepsis after the rash has faded* Birkhaug 
found the incidence of septic complications low in cases 
treated with Dochez.* s serum prior to the fourth day of 
disease, and also that cases presenting septic complica­
tions yielded slowly and irregularly to serum. O'Brien 
at first believed that no antitoxin or other serum 
available had any direct action on septic complications. 
He qualified this opinion with the remark that many 
further observations were required before a definite 
conclusion could be reached. The record of the present 
series (Tables Nos.7 le 8) is in direct disagreement with 
the later conclusion of Birkhaug.
TWBIÆ No*7.
(52)
# cases in each group which developed complica­
tions.
Alveolar Abscess. 3% i;5%
Abscess of scalp 1.5%
Mastoiditis 1.5%
Otorrhoea 17% 21% 44%
Rhinitis 9% 44%
Septic Finger 3% 1.5%
" Toes 1.5%
Ulcerative stomatitis 11%
Tonsillitis 3% 11%
Purulent post nasal discharge 1.5% 11%
Total 25 42 121
Proportion 1 1.8 5
22.
(4)
Benson and Maciver found that the administration 
of serum even on the first day of illness apparently does 
not act as an absolute safeguard against the subsequent 
development of septic complications during convalescente. 
These are the only authors who have considered the effect 
of antitoxin on the onset of complications and their 
report deals only with septic complications. This 
observation is confirmed in the present series as the 
results arranged in Table No*8. testify.
TABLE No. 8.
Day of illness on which complication developec
1 Alveolar abscess
i
25th 12th
1
Abscess of scalp 8th
Mastoiditis 5th
Otorrhoea 16th 11th 16th
Purulent rhinitis 18th 13th
Septic fingers 45th 51st
” toes 33rd
Ulcerathve stomatitis 23rd
Tonsillitis 29th 18th
Post nasal discharge
!
81st 8th
: Average 29th 27th 16th
Proportion 1 1 0.6
Gordon states that the favourable effect of 
scarlet fever antitoxin or serum is evidenced by a lessened 
severity and duration of all complications. The findings 
in the present investigations as shown in Tables Nos.9 and 10 
do not support Gordon^ statement.
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TABLE No.9.
showing the duration In days of septic complications 
in groups I, II and III,
Group I. Group II, Group III.
Alveolar abscess 3 days
! Abscess of scalp 25 days
Mastoiditis 5 " 9 days
Otorrhoea 15 ” 30 " 33 "
Purulent rhinitis 17 ” 19 " 29 ”
Septic fingers 5 " 5 ”
Septic toes 5 " 5 "
Ulcerative stomatitis 8 "
Tonsillitis 18 ” 18 "
Purulent poet nasal 
discharge 12 ” 8 "
Average durâtion 9 days. 15 days 11 days, j
Proportion 1 1.7 " 2 "
TABLE No. 10.
showing the duration in days of non-septio complications 
in groups I. II and III.
Group I Group II. Group III.
1 Adenitis 4 days 6 days 10 days
Arthritis 6 II 7 "
Endocarditis 25 II 37 "
Nephritis 14 II 23 " 16 days.
Serous rhinitis 3 II 34 ” 10 ^
Br onchopneuffionia 4 II
Lobar Pneumonia 4 It
Tonsillitis 5 II
Average duration 8 days 21 days 12 days.
Proportion 1 2.6 1.5
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From the more detailed analyses of the present 
series, hovmver, more exact findings are obtainable.
Thus tables Nos.11 and 12 demonstrate that while powerless 
to delay the onset of non-septic complications, serum 
has the effect of diminishing the frequency of their 
occurrence•
TABLE No.11. 
showing the onset of non-septic complications 
in groups I, II and III.
Group I. Group II Group III.
day of illness "3ay of iTlness ïïay of mines
Adenitis 17th 10 th 14th
Arthritis 10th 11th
Endocarditis 27th 19th
Nephritis 20th 10 th 44th
Serous rhinitis 15th 16th 5th
Broncho pneumonia 6th 5th
Lobar pneumonia
Rheumatic Tort i coliés 8th
Average 15th 13th 17th
Proportion 1 1 1*3
TABLE No.12
showing the incidence of non-septic complications 
in groups I, II and III.
Group I. Group II. Group III.
Adenitis 17^ of cases 15# of cases 33# of cases.
Arthritis 13% " 8# " "
Endocarditis 10# " 3# " "
Nephritis 17# " 6# ' " 11# " "
Serous rhinitis 10# " 3# " " 11# " "
Bronchopneumonia 3#
Lobar pneumonia 11# " "
Rheumatic Torticolles 3#
Total 73# 35# 66#
Proportion 2 1 1.8
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Table No.13 gives details of the individual complications 
encountered
TABLE No.13.
showing the incidence, day of onset and duration of 
complications in groups I, II and III.
Complication % cases 
developing 
complications.
Day of illness 
6n which compli­
cations occurred.
Duration of 
complication, 
in days.
I II HI I II Ill I II III
Alveolar Abscess. 3^ 2% 25th 12th 3 84
Abscess of scalp 1.5% 8th 25
Adenitis 17^ 15% 33% 17th 10th 14th 4 6 10
Arthritis 13% 8% 10 th 11th 6 7
Endocarditis 10% 3% 27th 19th 25 37
Mastoiditis 1.5% 5th 5
Nephritis 17% 6% 11% 20th 10 th 44th 56 23 16
Left otorrhoea 10% 9% 22% 16th 11th 16th 22 37 25
Sight otorrhoea 7% 12% 22% 8 22 39
3ronchbpneumonia 3% 6th 4
Lobar pneumonia 11% . 5th died
Serous rhinitis 10% 3% 11% 15th 16th 5th 17 34 10
Purulent " 9% 44% 18th 13th 19 29
Septic finger 3% 1.5% 45th 51st 5 4
Septic toes 1.5% 33rd 5
Ulcerative stomatitis 11% 23rd a
Tonsillitis 3% 11% 18th 18th 18 18
Torticolles 3% 8th 5
Purulent post nasal 
discharge. 1.5% 11% 81st. 8th 12 8
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Duration of Residence in Hospital.
The cases of scarlet fever in Group I, which were 
not treated with antitoxin, had an average residence of 
56 days. The cases in Group II treated with 10 c.cms, 
antitoxin resided on an average 53 days, while the cases 
in Group III, treated with 20-30 c.cms. antitoSin 
resided 58 days. No attempt was made to dismiss cases 
at the earliest possible opportunity, as it was 
considered desirable to keep the cases under close 
observation throughout the entire illness and period of 
convalescence.
6. CONCLUSIONS.
1. Scarlet fever streptococcus antitoxin is of definite
therapeutic value in scarlet fever.
2. There is evidence that scarlet fever streptococcus
antitoxin has some iffeet in reducing the occurrence of 
non-septic complications.
3. There is no evidence that scarlet fever streptococcus
antitoxin -
(a) Diminishes the occurrence of septic complications.
(b) Delays the onset either of septic or of non-
septic complications, or
(c) Shortens the duration of septic or non-
septic complications.
*
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SECTION 2.
1. Evolution and Present Status of the Schultz-
Charlton Reaction.
2. Technique employed in the Present Investigation.
3. Results obtained from the Present Investigation:-
(a) Effect of Diluting the Serum.
(b) The Time Interval of the Reaction.
(c) Estimation of the Potency of the Serum.
(d) Effect of Antiscarlatinal Serum on
the Schultz-Charlton Reaction.
4. Conclusions.
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I, Evolution and Present Status of the 
Schultz-Charlton Reaction.
(58)
Schultz and Charlton treated patients in the
acute stage of scarlet fever with serum obtained from
others in the convalescent stage. On the day
following injection they noted that the rash had faded
over a small area surrounding the site of injection.
Investigating the matter further, they injected 0 . 5 - 1  c.cm.
of ”convalescent serum" intradermally into patients in
whom the rash was still present and observed blanching of
the rash for one centimetre around the point of injection#
It is important to note that similar results were
obtained with normal human serum. The blanching, to
which the y gave the name of "serum extinction phenomenon"
and which is now known as the Schultz-Charlton blanching
test, did not appear until five to six hours after
injection and persisted until the rash faded. Schultz 
(38)
and Charlton concluded that the serum of a patient 
convalescent from scarlet fever "recovers its lost 
power of blanching the rash between the fourteenth and
(22)
nineteenth day". This indicates as Levin and parsons
point out, that the capacity for blanching rashes is a
property of normal human serum, temporarily lost during
the acute stage of scarlet fever, but regained during
convalescence. Further work on the Schulta-Charlton
(43) (29)
reaction has been done by Tron and MulsW, who
did not find the reaction positive stifficiently often
to constitute a reliable method of differential
(20)
diagnosis. Their results are confirmed by Hazelhorst
who found the reaction negative in 20# of cases of
(35)
undoubted scarlet fever. Rojo had a high percentage 
of/
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of positive results and found the reaction consistently
negative in four cases of non-scarlatinal eruptions.
His results therefore support the specific and reliable
(34)
nature of the test. Raymond used normal serum in his
series and had a high percentage of positive results,
but no blanching occurred in Neumann's series in which
(16)
foreign serum was employed. Dorner obtained 85#
positive results with serum obtained from convalescents
(59)
six weeks after the onset of scarlet fever. 8teinko#f 
obtained 83.7# positive results in fortynine cases.
He states that the eruption does not merely blanch, but 
that all its elements retrogress, and that a positive 
result on the first or second day of eruption seems to
(42)
be characteristic of scarlet fever. Toomey and Nourse 
as a result of their study of one-hundred and thirty- 
three cases and twenty-two controls concluded tiat some 
normal serum produces no blanching at all, and that 
this fact limits the application of the test in its 
negative phase.
(8)
Blake, Trask and Lynch used the immune serum
of Dochez and Sherman obtained by injecting a horse with
haemolytic stBptococci. Blake produced blanching in all
(5)
of his thirteen cases and Birkshaug in forty cases.
(14)
Dochez and Sherman were unable to produce an immune
serum by injecting a horse with the filtrate of
cultures of haemolytic streptococci. The serum used
(22)
by Levin and Parsons was prepared by a commercial 
manufacturer by injecting horses intravenously with 
whole cultures of haemolytic streptococci from a case 
of scarlet fever and also subcutaneously with the 
f&itrate (toxin) of these organisms. Levin and Parsons 
obtained blanching in fifteen cases with this specific 
antiserum./ : ' Tc
50.
antiserum. They concluded that this specific antiserum 
was of practical use in the diagnosis of scarlet fever 
on account of the difficulty in obtaining normal or 
convalescent serum.
Kinloch obtained 89.6# positive reactions in 
one hundred and thirty-five patients, with a higher 
percentage of positive results in cases in which the 
rash was at its height than when it was beginning to 
fade (i.e. 92.1# of forty-seven cases, as compared with 
88.1# of eighty-four cases.). le suggested that failure 
to blanch might be due to known differences in the 
strains of scarlatinal streptococci, and concluded that 
the impossibility of obtaining a definite reading in 
rashes, which are not at the height of their development, 
limits the value of the test.
At present there is no laboratory method by 
which the potency of scarlet fever antitoxin can be 
estimated. In America the "skin neutralisation method" 
of testing sera is used. In this method a subject 
giving a positive Dick reaction is injected intradermally 
with a fixed dose of toxin and varying doses of antitoxin, 
until the smallest dose of antitoxin, which will neutralise 
the toxin, is found. On this finding a system of units 
is based.
Further work done on the above lines indicates that 
the method is not sufficiently accurate. An accurate 
method of estimating the value of an antitoxin which does 
not involve the use of volunteers, would be of practical 
utility. The following testing of sera by the minimal 
blanching dose of Schultz-Charlton method has been carried 
out in an attempt to supply this want.
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2. Technique Employed In the Present Investigation,
The cases of scarlet fever on which the Bchultz- 
Charlton tests were done were similar to those included 
in the groups already described. Cases were selected 
which had a bright rash of uniform intensity on the 
abdomen, and 6f not more than fortyeight hours' duration.
The same record syringe and similar needles were used in 
all cases. The test consisted in injecting 0.1 c.cms. 
of serum intradermally into the abdominal wall, when a 
circular wheal formed at the site of injection. The 
serum used in these tests was obtained by intramuscular 
injection of horses with the toxin of the scarlet fever 
streptococcus. The serum was then concentrated. 
Corresponding dilutions of two sera of unknown strength 
were injected into a patient, and two sets of investigations 
consisting in all of four Schultz-Charlton tests were 
carried out simultaneously on the same patient. The 
time elapsing between the injection of serum and the 
appearance of an area of blanching at the site of 
injection was noted, and as the tests were carried out 
in exactly the same way on precisely similar patients, 
the results are strictly comparable as far as their 
nature permits.
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3. Results Obtained from the Present Investigation.
(a) Effect of Diluting the Serum.
There are few published records of the results of 
the Schultz-Charlton test with diluted sera. In the 
present investigation theréfore it was thought desirable 
to obtain information on this point, and several definite 
conclusions have been reached.
In the first place the blanching power of a given 
serum tested on a series of patients is not directly 
proportional to its concentration. This is clearly 
demonstrated in the accompanying table.
TABLE No. 14.
Dilution. # of cases.
Undiluted 100# of 8 cases
1-1,000 50# of 24 "
1-2,000 0# of 6 "
1—4,000 76# of 8 "
1-8,000 36# of 14 "
1-16,000 22# of 18 "
lT24,000 25# of 24 "
1-32,000 50# of 6 "
1-36,000 12# of 8 "
At the same time it is equally clear that in extreme 
dilutions the possibility of error is so great that 
for diagnostic purposes any dilution of 1 in 1000 or 
higher is nf no value. Thus at a dilution of 1 in 1000 
only 35# of positive results were obtained in a total 
of twenty cases, while only 40# of positive results 
were obtained in the thirteen patients who were tested 
with a dilution of 1 in 2000.
TABIE No. 15.
33.
Serugi. Dilution. No.of 
cases.
No.of + 
results.
Variation 
in hrs.
Average.
8.A.4462 Undiluted. 4 4 G& - 40j-
hrs
26
S.A,4565 !l 4 4 6^ - - 40^ 26
8.A.4462 1-1000 8 6 iii - 41# 26
8.A.4565 tt 8 5 2& - 31 20
S•A •4462 1 -4,000 4 3 18* - 22* 21
8.A.4565 ti 4 3 17* - 22* 19
S.A.4462 1 - 8,000 4 2 16* - 22* 19
8.A.4565 M 4 3 15* - 22* 19
8.A.4462 1 - 12,000 4 1 19
8.A.4566 II 4 0
8.A.4462 1 - 16,000 6 2 8* -15* 12
8.A.4565 If 6 1 17
1 8.A.4462 1 -24,000 10 3 2s - 15* 10
8.A.4565 II 10 2 9* — 18 14
8.A.4462 1 - 36,000 4 1 11
8.A.4S65 II 4 0
8•A •4462 1 —1,000 4 0
8.A. 4571 II 4 1 12
S.A.4462 1 -12,000 4 0
S.A.4571 II 4 0
8.A.4462 1 - 24,000 2 1 21
8.A.4571 II 2 0
S.A.4462 1 - 2,000 3 0
8.A.4488 II 3 0
8.A.4462 1 - 8,000 3 0
8.A.4468 II 3 0
1 8.A.4462 1 - 16,000 3 0
8.A.4488 II 3 1 13
'8.A.4462 1 - 32,000 3 1 13
8.A.4488 II 3 2 13* - 15* 15
#4.
These results show that for practical purposes it 
is essential to use either undiluted serum or serum 
diluted to 1 in 10, or 1 in 100, and the accompanying 
figures prove that in such dilutions a high percentages of 
positive results are obtained#
TABLE No#16.
Serum Dilution. No.of 
cases.
No.of+
resuits.
Blanching 
time.
Average.
Hour8 . Hours.
A.C.1217 1-10 5 5 2-18* ! 10
EC 1217 If 5 5 1-14* 1 8-
!lC 1204 ti 4 3 7*-12
KG 1204 « 4 3 8-18* 1 15
AG 1216 II 3 3 20-21 1 20
EG 1216 II 3 2 20-21 21
AC 1217 1-100 5 5 1 7*-23 8
EG 1217 II 5 5 3-23 8
AG 1204 It 4 3 12*-20* 1 IG
EG 1204 II 4 3 18^23* 21
AG 1216 II 3 3 19
EG 1216 II 3 2 14i-21 i 18
j . - _ ....
SA 4462 Undilute d 4 2 3i-5i
1
5ti 1-10 4 3 4 ^ 6 5« 1-100 A # 44—8* 6
AG 1217 1-1000 3 0
EG 1217 II 3 P
AC 1204 II 3 0 I
EG 1204 i II 5 2 11*-19* 16
AG 1216 1 It S 2 10-19* 15
EG 1216 II 3 3 9-20* 16
AC 1217 1-2,000 3 0
EC 1217 II 3 0
AC 1204 II 1 0
EG 1204 II 1 0
AC 1216 II 2 1 20*
EG 1216 II 3 2 11*-20* 16
II.
III.
IT.
V.
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Thirdly it is apparent from tables 14 and 15 
that undiMted serum gives the most accurate results 
(100# positive in eight cases).
Fourthly that there is no advantage in a 
dilution of 1 in 10 over a dilution of 1 in 100 is shown 
by the results recorded in table 16.
Turning now from the practical aspect it is 
of interest to enquire as to the highest dilution which is 
capable of yielding a positive result. It will be seen 
from tables 14, 15, and 17 that occasional successes 
may be encountered at dilutions of 1 in 36,000.
TABIE No.17.
Serum. Dilution. No.of 
cases.
No.of + 
results.
Variation 
in hr s.
Average.
8A 4462 1-32,000 3 1 13
SA 4488 3 2 15
SA 4462 1-36,000 2 1 21
Over the entire series of 256 tests, 
employing All strengths from undiluted serum down to a 
dilution of 1 in 36,000, a total of 116 (or 45#) of positive 
results were secured. It would appear therefore that 
the reaction should be regarded as possible in extreme 
dilution but reliable only in undiluted or slightly 
diluted sera.
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(b) The Time Interval of the Reaction.
Another question calling for investigation was
the time interval between the injection and the appearance
of blanching. The shortest interval reported by 
( 5)
Birkhaug was six hours. In this series the Schultz-Charlton 
reaction appeared one hour after the injection of a 
specific antitoxin in a dilution of 1 in 10, and in another 
case the same dilution of this serum produced blanching 
in two hours (see Table 17) .
Birkhaug states that the longest interval 
between the injection of specific antitoxin and the 
appearance of blanching was eighteen hours. In this 
series the blanching time was longer than eighteen 
hours in fortyseven tests, the maximum blanching time 
being forty-one and three quarter hours.
(c) Estimation of the Potency of the Serum.
--------- TE)--------
Birkhaug in considering the results 
obtained by testing normal human serum, convalescent 
scarlet fever serum and specific antitoxin by the 
Schultx-Charlton method, states that considerable 
importance and therapeutic value may be attached to 
the difference in potency of the blanching properties 
of these sera, and is of opinton that this difference 
may serve to establish a rough quantitative measure of 
specific antitoxic capacities contained in each of 
the three sera.
It might therefore be thought that the
Schultz-Charlton method of testing sera would give
some indication of the potency of specific antitoxin,
and that from testing sera in this way one might be
able to tell the clinician that unless a serum produced
blanching in a certain dilution it would not be 
sufficiently/
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sufficiently potent to be of use clinically. After 
testing the specific sera of unknown potency, undiluted 
and in varying dilutions up to 1 in 36,000 in 256 
Schultz-Charlton reactions^ I found it impossible to
draw any conclusions regarding the antitoxic capacity of 
the sera. The actual results are set out below;
TABIE No.18.
Dilution. Jase numbers. 8.A.4462. S.A.4565.
Blanching time in hours.
I.Undiluted. 38 24* 25#
39 40* 40#
II. 1-1000 38 25f -
39 41# -
III. 53 - 21*
IV. 1-4,000 43 22# 18*
V. 1-12,000 51 18g —
VI. 1-24,000 51 - 9#
VII. 1-36,000 57 _ 11#
S.A.4462 S.A.4571.
VIII. 1-1,000 59 — 12#
IX. 1-24,000 64 21* —
X. 1-36,000 64 21* -
Table No.l8 shows that in results II, IV, V and 
VII S.A.4462 appears to be a stronger serum than S.A.4565 
while in results III and VI 8.A.4565 appears to be a 
stronger serum than S.A. 4462.
The result VIII S.A. 4571 appears stronger than 
S.A.4462 while in IX and X the opposite conclusion seems 
justifiable. From this it is evident that the Schultz- 
Charlton test cannot be regarded as even a rough method 
of estimating the titre of an antitoxin.
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(d) The Effect of Antiscarlatinal Serum on 
Schultz-Charlton Reaction.
So far no reference has been made to the 
effect upon the Schultz-Charlton reaction when antiscarlatinal 
serum is given in therapeutic doses. Obviously the question 
is of considerable interest and has a clinical application, 
but equally certain is it that this information must not 
be gained by the sacrifice of or encroachment upon the 
patient's chance of recovery. While scrupulously 
observing this principle an attempt has been made to 
determine (a) whether the Schultz-Charlton reaction is 
at all affected by the giving of the usual dose of serum 
and (b) how soon after the injection in the Schultz- 
(Siarlton test can anti-scar latinal serum be given without 
invalidating the result of the test.
Only a guarded answer can be given, however, 
as the number of cases investigated was too small. It 
would appear that the administration of serum prior to the 
Schultz-Charlton test does prevent the blanching, which 
would otherwise have occurred. Thus in both cases 
tested a negative result was obtained, despite the fact 
that the serum used had given positive results in 15-80# 
of cases in previous tests. The details of the experiment 
are set out in Table No.19.
TABIE No. 19.
Case
Nos.
Schultz-
Charlton.
Dilution.
No.o'f hours
following
administration
of 10 c.cms. ant
toxin at which
Schultz-Charlton
performed.
Re suit.
L-
26 8A 4462 Undiluted 31 hours —
23F 8A 4462 Undiluted
1-10
1-100
2f hrs.
- - -....
—
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In case 26, although the rash was bright when 
the Schultz-Charlton reactions were performed, it was 48 
hours old and therefore in the late stage of capillary 
paralysis and did not respond. In case 27, however, the 
rash was only a few hours old, yet no blanching occurred. 
This would seem to indicate that the 10 c.cms. antitoxin 
had begun to have an effect on the generalised rash 
preventing later local blanching reactions.
Approaching the question in another way I 
carried out seventeen tests at varying intervals before 
the administration of the serum, the intervals ranging 
from one half to twenty hours. Six positive results 
were obtained, but no conclusion could be reached as 
to how soon after the initiation of the Schultz-Charlton 
test antiscarlatinal serum can be given without interfering 
with the blanching. The actual experimental details 
are contained in Table No.20.
TABLE No.20.
Case
No.
se rum. Dilution.
Fo. of hours after 
Schultz-Charlton a 
which 10.c.cms. 
antitoxin given.
t Result
41 8A 4462 ) 1-4000) 4* hrsr
2A 4565) 1-4,000) 20* " -
8A 4462) 1-8000)
8A 4565) 1-8000) —
43 SA" 4 4 ^ H-4obo)
8A 4565) 1-4000) 5* hrs +18# "
8A 4462) 1-8000)
SA 4565) 1-8000) +18# "
45 SA 4462) 1-16000) 9* hrs.
8A 4565) 1-16000) 20 " -
8A 4462) 1-24000)
8A 4565) 1- 24000) —
46 1 8A 4462) 1-1600) * hr. L
8A 4565) 1-16000) 7* hrs. —
8A 4462) 1-24000 ) —
8A 4462) 1-24,000) —
-ro­ 8A 4462 Undiluted 12 hrs. ' 5* hrs.
1-10 6 "
1-100 4- 8* "
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4. CONCLUSIONS.
1. The blanching power of a given serum is not 
directly proportionate to its dilution or 
concentration.
2. With very dilute solutions the results are
quite unreliable although positive results 
may occasionally be obtained.
3. In practice it is inadvisable to use a dilution
higher than 1 in 100.
4. The most accurate results are given by undiluted 
serum.
5. If the serum is diluted it matters little whether 
the strength used is 1 in 10 or 1 in 100.
6. The time interval between initial injection and the 
appearance of blanching varies within wide limits 
(1 hr. to 40 hrs.) .
7. The Schultz-Charlton technique cannot be regarded 
as even a rough method of estimating the potency 
of a serum.
8. The scanty evidence available suggests that the
previous administration of scarlatinal antiserum 
interferes with the blanching.
9. It has been found impossible to determine how soon
after the start of the Schultz-Charlton test one 
can give antiserum without affecting the local 
blanching of the rash.
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SECTION 3 .
1. Objects of the Present Investigation of the Leucocytes.
2. Results previously obtained by other Observers.
3. Technique employed in the Present Investigation.
4. Results obtained in the Present Investigation regarding:
(a) Initial Leucocytosis.
(b) Behaviour of the Leucocytes in the
course of the Disease.
(c) Effects of the Anti scarlatinal Serum on
the White Cell Count.
(d) The Differential Cell Count.
5. Conclusions.
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I. Objects of the Present Investigation of 
the Leucocytosis.
We have seen that the commercial serum used 
throughout this series gave definite clinical results.
We have observed also that it was instrumental in 
diminishing the liability to non-septic complications 
although it had no influence on those of a septic 
nature, and lastly we know that from the technique 
of its production it is claimed to be both antitoxic 
and antibacterial.
In view of the considerations it was considered 
desirable to investigate the question of leucocytosis 
in scarlet fever with the object of determining:-
(a) whether the administration of the specific antistrepto­
coccic serum affected the leucocyte count in any way.
(b) whether the leucocytosis was dependent entirely upon
the severity of the disease;
(c) whether the obset of complications could be surmised
from the behaviour of the white cell count, and
(d) whether the differential count would reveal more
than the total count.
One aspect of the differential count, i.e. eoslnophilia, 
has been purposely omitted - and that for a very definite 
reason.
2. Results previously obtained by Other Observers.
The presence of eoslnophilia in scarlet fever
has long been recognised and has been considered
characteristic of this disease, as it was not found in any
other infection. Recent investigations of the phenomenon
(30) (1)
in scarlet fever have been made by Nfigeli, Ambrus,
(24)
Markovitch and Gueratovitch. Ambrus considered
that/
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that the prognostic value of eosinophils was high, 
Markovitch and Gueratovitch estimated the diagnostic value 
of eosinophils
(a) in cases free from complications, in which they found
the eoslnophilia highest,
(b) in cases which developed complications, in which the
eosinophils varied between 1 - 3#, and
(c) in severe and fatal cases, in which they found that
eoslnophilia was absent.
(7)
Bix studied the lymphocyte and eosinophil curves and
the variation in these caused by the occurrence of
complications. He concluded that in the days elapsing
between the height of the exanthem and its disappearance
(average 4-7 days) one could estimate the day of scarlet
fefver with a fair degree of accuracy, by the appearance
of the lymphocyte and eosinophil curves. The presence and
significance of eosinophils in the blood picture in
scarlet fever has therefore been fully investigated and
accordingly it is not considered in this work.
(27)
Mironesco and Farcas found that the administra­
tion of Dochez's antitoxin reduced the number of leucocytes
(6)
in six cases of scarlet fever, while Birkhaug found that 
the blood picture of the patients treated with Dochez*s 
serum proved to be an index of the activity of the serum, 
for hyperleucocytosis and polymorphonucleosis decreased 
in a critical manner within twenty four hours after 
administration of serum. He also found that when the 
leucocytes had reached the normal, they remained so 
throughout convalescence.
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3. Technique employed in the Present Investigation.
The blood was taken from the patients on admission 
and again on the third and seventh days thereafter. The 
same pipette, counting slide, diluting medium and 
microscope were used in each case. The blood films for 
the differential estimation were stained with Leishman's 
stain and two hundred cells were counted each time.
4. Results obtained in the Present Investigation, 
(a) Initial Leucocytosis.
The actual results in the several groups are set 
out in the accompanying table:-
TABLE No.21.
Group No. Average White Cell Count.
1 20,388 per c.mm.
2 20,203 If I
3 31,450 I I
4 29,250 fi I
5 (one case) 22,400 I I
6 (two cases 18,400 If If
from which it appears that:-
(1) The leucocyte count is a less reliable index of the
severity of the disease than is the general clinical 
picture. Thus the patients in group 2 were judged 
to require 10 c.cs of serum, whereas in those in 
group 1, serum was considered superfluous.
Nevertheless the leucocyte count fails to differentiate 
the two groups•
(2) Onthe other hand we note that group 3 was characterised
by a definitely higher leucocytosis, but, in this 
ease/
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case, the patients required 20-50 c.cs. of serum. In 
other words, a pronounced leucocytosis is common in severe 
cases, but the unaided senses yield a more critical 
differentiation. In patients whose leucocyte count could 
be taken as a guide, no such index is required.
(3) The above censure applies only to a leucocytosis, however, 
and not to a virtual leucopoenia, which we find in the 
septic and toxic groups (Nos. 4 and 5). Here the obvious 
discrepancy between the clinical findings and the leucocyte 
count amounts to a special signal of warning.
Can we by further investigating the initial 
leucocyte count obtain any indication as to which patient 
is prone to develop complications and which is likely to 
escape them? The answer - in the negative - is to be 
found in the data of Table No,25 in which the details are 
given for the first three groups.
TABLE No.22.
diroup
No. Initial Leucocyte Count.
Cases without Cases which Average for
complications. ieveloped complicated ®nd
complications. uncomplicated cases.
I 22,125 per c.m.m. 18,650 per 20,388
c .mm.
II 17,456 " " 22,950 " 20,203
III 14,300 " " 48,600 " 31,450
*h H-
r
r+h
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(b) Behaviour of the Leucocytes in the 
Course of the Disease.
What is more - we cannot obtain this information 
by tracing the behaviour of the white cell count during 
the course of the disease. This is strikingly proved by 
the graphs (Nos.23, 24, 25 and 28) from which it is evident 
that our attempts may be baffled by two separate factors. 
These are (a) that a rise in the leucocyte count may occur 
in an uncomplicated case between the 3rd and 7th day 
(Charts 24, 28) and (b) that in the complicated cases the 
advent of a secondary leucocytosis may easily be masked 
by the failure of the initial high reading to reach a 
normal level before the secondary rise might be expected to 
supervene - see graphs Nos. 24 k 25.
We are therefore forced to the conclusion that the 
leucocyte count can seldom be used as an index either of the 
severity or of the progress of the case with respect to 
the probable onset of complications. It is, however, 
perfectly clear that both in uncomplicated and in complicated 
cases a pronounced fall in the white cell count between the 
first and the third day is a constant finding.
The exceptional cases excluded from the previous 
generalisation comprise the toxic and septic types, to 
both of which groups in addition to the initial constant 
fall a second feature is added, viz. a definite rise in the 
white cell count after the third day, until by the seventh 
day the initial level was exceeded. This is shown 
graphically in charts Nos.26 and 27.
f T
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(c) Effect of Scarlatinal Serum on the White Cell
C ount.
The question nov/ arises whether we can trace any 
effect on the leucocyte count, which might reasonably be 
attributed to the serum. In the comparatively mild cases 
no such influence is apparent as witness graph No#29. 
Although the difference in the numbers of the white cells 
is scarcely beyond the range of experimental error, it would 
be fallacious or at least unguarded to yield to the 
tempting suggestion that the serum treated cases showed a 
smaller increase from the 3rd to the 7th day.
(d) The Differential Cell Count.
In the present series the number of cases of 
toxic and septic fever is too few to permit of any 
generalisations regarding the differential white cell count.
In the milder cases, i.e. the patients of groups 1, 
2 and 3 the outstanding features may be summarised thus:-
(1) A polymorphonuclear leucocytosis was the rule, but
the excess of polymorphs was slight.
(2) The proportion of polymorphs did not undergo much
variation throughout the course of the disease.
(S) The proportion of polymorphs did not differ
characteristically in the complicated and uncomplicated 
cases.
(4) Neither did the subsequent behaviour of the polymorphs 
distinguish the simple from the complicated cases.
These deductions are most easily shown by arranging 
the relevant facts in tabular form.
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TABLE No.30.
r" "  " POLYMORPHS.
Group Group 2T Group S.
1 ____
Admis­
sion.
3^days " 
after.
Todays 
after.
Adml s- 
sion.
oasija
after.
7 days
after •
Admis 
3 ion
-3 days 
after.
7 days 
after,
pwomplicated 83.5# 78.6# 78.S# 88% 61% 67% 85.5% 65.5% 65%
Complicated 77.7# 66# 64.8^ 88% 65% 70% 94% 74.5% 73.5%
Dotal 80.6# 71.8# 71.6^ 88% 63% 69% 89% 69% 69%
Turning now to the other cellular elements, the 
most constant feature was the behaviour of the large and 
small lymphocytes as shown in the accompanying table 
(No.31) • From the first day onwards the small lymphocytes 
undergo a steady and constant increase. The large 
lymphocytes on the other hand increase from the first to 
the third day, but decrease thereafter until by the 7th day 
their original level has virtually been regained.
TABIE No.31.
TARGE LYMPHOfflYTES.
Group I. Group 2. Group 3.
Admis­
sion.
3 days 
after.
7 days 
after.
'Adml s- 
sion.
^ T a y s
after
7 days 
after
‘Admis­
sion.
" 3^dâÿg 
after,
7 days 
after.
fnGomplicat<
1
i/omplicated
Total
)d 6.3# 
9.4# 
7.9#
8.1%
12.8%
10.5%
7.5%
9.8%
8.7%
7%
6%
7%
12%
14%
13%
10%
9%
10%
8%
2.5%
5%
25%
9.5%
17%
14%
9%
11.5%
^^®omplicat€
Complicated
Total
d 8.8# 
13.4# 
11.1#
9.8% 
19.4% 
14.6%
13%
83%
18%
SMALL
7%
5%
6%
LYMPHOC
19%
19%
19%
!YTES.
23%
18%
20%
6.5% :
3.5%
5%
11.5%
16%
13.7%
20.5%
17,5%
19%
L
From the same table it can also be seen that 
this constant curve is independent (a) of the occurrence 
of non-occurrence of complications and (b) of the 
giving/
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giving or the withholding of serum.
It is of interest to note that the minimum 
reading of large lymphocytes occurred on admission in a 
case of toxic scarlet fever, which had a fatal issue.
A comparison of graphs Nos.32-30 shows that 
the greatest excursion in large lymphocytes from minimum 
to maximum occurs in cases developing complications in 
the following order - (1) nephritis, (2) arthritis,
(3) serous rhinitis, (4) cervical adenitis, (5) purulent 
rhinitis, i.e. the greatest rise in large lymphocytes 
on the third day occurs in the most "se&tic" 
complications. As the majority of these complications 
were not manifest clinically until after the seventh day 
of illness, it would he unwise to draw any conclusions 
regarding the effect of complications on the large 
lymphocyte from the above findings. Nevertheless it is 
possible that the complications were latent and 
influenced the blood picture during the first seven days.
Lastly it should be noted that only the figures 
necessary for the essential deductions have been 
incorporated here. Full details and further graphical 
representations are contained in the appendix.
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5. Conclusions,
lo The leucocyte count is a less reliable index of 
the severity of scarlet fever than is the 
general clinical picture.
2. The leucocyte count can seldom be used as an
index of the severity or of the progress of a 
case of scarlet fever with respect to the 
probable onset of complications.
3. In uncomplicated and complicated cases of
scarlet fever a pronounced fall in the white 
cell count, between the first and third day, 
is a constant finding.
4. There is no evidence to indicate that the
administration of antitoxin in cases of scarlet 
fever has any effect on the leucocyte count 
from admission to the seventh day of illness.
5. In cases of scarlet fever;-
(a) A polymorphonuclear leucocytosis is the rule,
but the excess of polymorphs is slight.
(b) The proportion of polymorphs does not undergo
much variation throughout the course of the 
disease.
(c) The proportion of polymorphs does not differ
characteristically in the complicated and 
uncomplicated cases.
(d) The behaviour of the polymorphs does not
distinguish the simple from the complicated cases
6. From the first day onwards the small lymphocytes
undergo a steady and constant increase.
7. (a) The large lymphocytes increase from first to
third day but decrease thereafter until by 
the seventh day their original level is 
virtually regained.
(b) This constant curve is independent of
(1) the occurrence or non-occurrence of
complications.
(2) the giving or withholding of serum.
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SECTION 4.
General Summary and Comment,
The clinical results detailed in the first section very 
strongly support the prevailing opinion that in the specific 
antiscarlatinal serum we have a therapeutic agent of great 
value. Its efficacy in curtailing the length of the acute 
stage of the disease is strikingly illustrated in the 
general improvement in the patients' * condition, and is 
reflected somewhat more slowly but equally clearly in the 
fall in the pulse-rate and the decline in the temperature#
Nor is this the only benefit. We have shown that the 
liability to non-septic complications is appreciably 
lessened, a result which may be reasonably attributed to 
arrest of toxaemic damage to the organs affected, e.g. 
the kidneys, At first sight it might appear strange that 
the common septic complications are not similarly checked, 
but it must be remembered that the patients concerned 
have already shown susceptibility to bacterial infection. 
Moreover, the administration of the serum cannot aid directly 
in the prevention of superimposed sepsis, because its success 
in scarlet fever depends entirely upon its being specific, 
and this very specificity dispels any hope of its being 
used effectively against other organisms, e.g. the various 
streptococci, staphylococci or Vincent's bacilli, which 
are responsible for many of the septic complications.
As to its mode of action, we cannot dogmatise, but
the results of the present enquiry would indicate that the
antitoxic element is more important than the antibacterial.
Thus, general clinical improvement precedes the resolution
of the buccal lesion, and prostration, a classical effect
of toxaemia, is among the first symptoms to vanish.
Further support for this suggestion is supplied by a study 
0%/
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of the leucocyte count. As has been explained fully 
in the last section, the administration of serum does not 
influence either the number of leucocytes or their 
characteristic behaviour in the course of the disease.
For the elimination and treatment of septic sequelae 
and the treatment of the non-septic, we must still rely 
upon general principles. And lastly, we must be guided 
by general principles and by the response to treatment in 
estimating the dosage of the serum, since we have as yet 
no method of titrating a given sample and no reliable 
method (the Schultz-Charlton we have proved fallacious) 
of determining the potency of a given serum in a given patient, 
perio
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TABLE No. 37
showing the average leucocyte counts in cases of ^ o u p  1. 
of' case'J
Uncomplicated 
cases
Complicated 
cases
Complicated 
+ uncompli­
cated
No.of
cases.
4
6
10
On admis­
sion.
22,125
18,650
20,388
No. of white blood corpuscles.
3 days
after admission.
15,150
12,167
13,659
"Tdays 
after admission,
14,722
16,350
15,536
TABLE No.38
showing the average differential counts in cases of Group 1.
case.
No.of 
cases
Uncomplica
ted
/compli­
cated
Uncompli­
cated + 
complicated
4
6
10
Polymorphs.
admis
sion
83.5^
77.7#
80.6#
3 days 
after
78.6#
65#
71.8#
7 days 
after
78.5#
64.8#
71.6#
Small lymph,
admis
sion
8.8#
13.4#
- 3 days 
after
9.8# 
19.4#
11.1# 14.6#
7 days 
after
13#
23#
18#
I Laÿge: Lymph
»Admi
sion
8-3 dys 
after
6.3^
9.4^
7.9%
8.1%
12.8%
10.5%
7
dys
aft.
7.5%
9.8%
8.7%
TABLE No.59
showing the average leucocyte counts in cases of Group 2
Type of No. of No. of white blood corpuscles.
case. cases. On admission. 3 days after 
admission.
7 days after 
admission. f
%ompli-
®fited. 7 17,456 10,628 13,186
Gomplica-
i^^ compll- 
®®ted -1- 
^^mplicat
20
27
5d.
t. —...
22,950 '
20,203
17,485
14,057
15,719
14,453
TABLE^j^j^.
xhowipp the average differentlalTcounts in cases of Group 2.
c^omplicated 
'“"“Plicated
^Complicated
^Complicated.
No. of 
cases
8
18
26
Polymorphs 
"Admits dys' 
sion. after
88#
88#
61#
66#
63#
7 dys. 
after♦ 
67% 
70%
69%
Small Lymph. 
AdmisJ 
sion.
w
¥
6%
5 dys 
after 
19% 
19%
19%
after
23%
18%
20%
Large Lymph
Adml
sion
w
6%
7%
!Tays
after
i w
14%
13%
>af te:
13#"
10#
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TABLE No.41.
showing the leucocyte counts in cases of Group 5.
Type of 
case
No.of
cases
  White blood, corjpuscles.
On a'dmission. 3 days after 
adrni ssion.
7 days after 
admission.
Uncomplicated
Complicated
Uncomplicated 4- 
oomplicated •
14,300
48,600
31,450
9,100
47,400
28,250
9,200
16,800
13,000
TABLE No. 42.
showing the differential counts in case* of Group 3.
Type of No.of Polymorphs. Small lymph. targe Lymph.
ease. cases. Admis­
sion.
3 days 
after
7 days 
after
Admis­
sion.
3 days 
after
7 dys 
after
Admis
.sion.
-3 dys 
afler
p 7djp 
tfter
Uncomplicated 1 85.5# 63.5# 65# 6.5# 11.5# 20.5% 8% 25% 14#
Complicated 1 94# 74.5# 73.5# 3.5# 16# .17.5% 2.5% 9.,'% 9#
Uncomplicated 
+ complicated.
2 89# 69# 69# 5# 13.7# ^ 19% •5% 11.5
TABLE No.43.
showing the average leucocyte counts incases of Group IV.
Type of 
case.
-
Total cases
No. of 
case*.
White b
On admission.
29,250
ood corpuscles.
3 days after 
admission,__
12,067
7 days after 
admission.
37,000
TABLE No.44
showing the differential counts in cases of Group IV.
' Type of case. No.of
cases
Polymorphs. Small
lymphocytes.
Large
lymphocyteS.
Admis­
sion.
3 days 
after.
7
dys
after
Admis­
sion.
3days
after
7 days 
after
Admis
sion
-3
dys
after
7
dys
after
Total cases 
___
4 i12# 70# 87# 12% 17% 7% 5# 8% 6%
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TABLE No. 45.
showing the leucocyte counts in cases of Group V.
Type of
case.
No. of 
cases. Whii;e blood corpuscles.
On admission. 3 days after 
admission.
7 days after 
admission.
Septic scarlet 
fever.
1 22,400 18,400 38,400
TABLE No. 46.
showing the dlfferentiaT counts in cases of Group V .
Type of case. No. of 
cases.
Polymorphs. Small Lymph. ; Large Lymph.
Admis­
sion
3 day: 
after
Î7 days 
after,
. Admis 
sion
—3 day 
after
s7 dys 
after
Admis
sion
- 3 7
dys
18% 5.$Septic scarlet 
fever. (
1 63.5# 82% 88% 17% 0% 6.5% 18%
TABLE No. 47. 
showing the leucocyte counts in cases of Group VI
Type of 
case.
No. of 
cases.
White blood corpuscles.
On admission. 3 days after 
adrni ssion.
7 days after 
admission.
uncomplicated 1 17,000 25,300 25,400
cases
Complicated 1 19,800 13,000 11,400
cases.
Uncomplicated 2 18,400 19,150 18,400
+ complicated.
... ......... 1..-.-___
TABLE Bo.48.
showing the differential counts in cases of Group VI
Type of 
case •
No. of 
cases J
Uncomplicated 1 
cases. 
Complicated 
cases.
Uncomplicated 2 
t complicated
PcO^ymor pLTI lym^bc y te
Adrni815 days 
sion. after
74#88#
85#
87#
65#
70#
T  days 
after.
large
lymphocytes. ' 
f Admis 13 days) 7(%ra 
after.I aft
12.5%
7 day 
after
Admis
sion. sion.
11.5%
74.5# 20.8%
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TABLE No.49.
No • Complication. Onset* Large Lymphocytes 0
Admission. 3 days 
after.
7 days 
after.
13,
24
Acute Nephritis 
t t  ri
26th day of 
illnes 
16th "
3.5%)
3 .  >6.5% 
10%)
6.5% )
)9.5% 
12.5% )
9%)
)11%
13%)
70
71
72
n  ti 
n n 
tf ri
Av(
15th " 
9 th " 
3rd "
îrage
4%)
6.5%)6.1%
6^ .4#^
8%)
10.5%)9.2%
9^^
9 . 3%^
10%)
8%) 7% 
3%)
““176%
18
81
j 112
Serous Rhinitis.
W II 
ti »
5th ” 
3rd " 
37th "
6%
4%
8.5%
18%
8%
6.5%
10%
6%
9%
Average 6.2% 10.8% 6.3%
82
85
Purulent Rhinitii
« M 3rd "
Lverage
3.5%
12%
-r.8%—
30%
15%
~ssj,—
5%
8%
~ e : w ~
19
20
Arthritis
It
8th " 
8th "
5.5%) n% 
8.5% ) 6 . 3  J
78
79
If
II
8th " 
7 th ” 7%^^ )6.3%
15%^1i3% 1^%^ e%
jiverage 6.6% 10% 7.5%
66 !
67
68
Cervical Adenitis
II II 
II It
11th " 
33rd "
6th " __
7.5%
5%
8.5% __
27%
8.5%
18%
17%
10%
15.5%
.verage 7% 17.8% 13.5%
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P A R T  II.
OBSERVATIONS ON TEB SEDIMENTATION RATE OF THE 
RED BLOOD G0RFU8CIE8 IN SEVERAL ACUTE AND 
CHRONIC INFECTIVE DISEASES.
1. Introduction.
2. Technique employed in the present investigation.
3. Results obtained in the present investigation and
a comparison of these results with recorded 
observations.
4. Discussion of the course of the phenomenon in
the light of recorded opinions and of further
analysis of the results of the present series.
5. Conclusions.
6. References.
1. INTRODUCTION. 61.
In many books of medicine published in the latter
half of last century, reference is made to the hastened
settling of blood in individuals suffering from inflammatory
conditions, and the phenomenon was considered an important
clinical sign.
Galen is credited with first calling attention to it
and with giving to it the name of crus ta phlogistica" while
John Hunter studied sedimentation in 1791, and noted that,
during an inflammatory process, erythrocytes settled more
(2)
quickly in plasma. A. century later John Ashhurst describ­
ed the **buffy coat" which was analogous to Galen's "crusta 
phlogistica". The phenomenon was practically forgotten when 
the practice of blood-letting and the theory of humoral
pathology fell into disrepute, until it was rediscovered by
(4) U)
Fahr&eus in 1918, while investigating pregnancy. Pahr&eus
introduced a method of estimating the distance through which
erythrocytes sediment in a given time, and this method was
(16) (8) 
modified in detail by Westergren and later by Henkel 
(5) (11)
and Pischel Linzenmeier by the use of calibrated tubes
introduced the time method of estimating sedimentation, in
which the time taken by erythrocytes to sediment a fixed
distance was noted.
(4)
The findings of Fahrâeus and his successors stimu­
lated general interest and many workers, especially in 
Germany, carried out further investigations. Unfortunately 
the dis-similarity in the technique employed, led to great 
difficulty in comparing the results of the different
(17)
observers. Zeckwer abd Goode11 in 1925, introduced a
simple method of estimating the sedimentation of erythrocytes 
in citrated blood, which was a modification of the original 
method of fahrâeus.
2. Technique employed in the present investigation.
The rate of sedimentation of erythrocytes in citrated 
blood was/
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was estimated by the method introduced by Zeckwer and 
(17)
Goodell by placing 2c.cs of 3% sodium citrate solution
in a 15 c.c. glass centrifuge tube and adding 8 c.c. blood 
obtained difectly from the patient's vein with a fine needle.
The blood and citrate solution was gently mixed by inverting 
the tube once, and thereafter allowing to settle for one hour, 
when the height of the column in c.cms. of sedimentèd red cells 
was read.
Throughout the entire series the readings were made at room 
temperature which was constant. One possible source of error 
was thus excluded. Again, the patients who suffered from 
infective conditions were all treated in a similar manner in 
open-air wards of the same fever hospital. The patients in 
the sanatorium lived in accordance with a specific regime and 
all patients were under a prescribed diet, so that the influences 
of diet exercise and treatment could be eliminated. A series 
of normal controls was obtained from apparently healthy members 
of the hospital staff who were living in the same surroundings, 
having the same diet and approximately the same amount of 
exercise.
3. Results obtained in the present investigations 
and a comparison of these results with recorded
observations.
Nees who used Linzenmeier's method, found the variations
in the sedimentation time so great that it was impossible
either to tabulate results or to attempt to estimate an average
sedimentation rate for a given disease. On the other hand,
(17)
.Zeckwer and Goodell concluded from observations on 125
individuals that every case showing a sedimentation rate faster
than 4.5 c.cms. was associated with pregnancy, Malignant tumour,
tuberculosis or inflammatory exudate# They also state that it is
a
highly probable thalyperson with a sedimentation rate under 5.5 
and over 4.5.c.cms. is suffering from cancer^pregnancy or
inflammation. Their results are supported by the findings in
the/
e«r
&
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the present series as is evident from the following tahle.
Thus in 81^ of the control cases, the reading was 8 c.cs or 
more, whereas in the abnormal cases, the nearest approximation 
to this figure was only 13^  ^which was obtained in the cases of 
scarlet fever. Again none of the normal cases gave a reading 
of less than 4 c.cms., whereas this was obtained in all the 
abnormal types.
TABIE Mo. 60.
Type of case 
examined.
Mo. Height in c.cms. of column of erythrocytes 
at end of one hour.
0-4.
^ cases in 
this group.
4-8.
% cases in 
this group.
8+.
% cases in 
this group.
Mormal 26. 19% 8lf
Scarlet fever 23. 4^ 83^ 13%
Diptheria 17. 6;!: 82^ ' 12%
Erysipelas 25. 12^ 88^ 0%
Pneumonia 30. 23^ 0%:
Acute Phthisis J.2. 17^ 83;;' 0%
unacute % 13. 54^ 46% 0%
Chronic 25. 19;^ 75% 6%
Total 50. 30g 68% 2%
Cerebrospinal 3. 100^ 0% 0%
Fever•
Encephalitis 2. 50^ ^ 30% 0%
lethargica
Enteric Fever. 4. 50% 50% 0%
(19)
Zeckwer and Goodell hold that the lack of a sharp line
of demarcation in sedimentation rate between normal and 
pathological cases, indicates the limit of usefulness of the 
test. While this must be admitted, it is noteworthy that the 
average reading for normal individuals is well above the average 
of any infection here recorded. (See chart Mo. 59)
Moreover the actual readings in the individual patients 
in the control group show a remarkably restricted range of error. 
( Bee chart Mo. 60).
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TABLE. No. 61.
Type of
case
examined.
No.
Height in c.cms. of column of erythrocytes 
at end of one hour.
0 - 4 4 - 8 8 +
Control 26 6.1 8.2
Case 7 8.4
7.9 8.4
8 8.4
8 8.5
8.8
8.8
9
9
9
9
9
9
9
9
9
9
9
9
9.1
9.2
Total cases 5 or 19% j 21 or 81%
======
It is in the abnormal groups that the possible variation 
is great.
Prom this It is clear that a low reading is of pathological 
significance, and we must now consider the influence of 
(1) age, (2) temperature and (3) the type of disease on the 
sedimentation rate*
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That age has no direct influence is shown by the 
results set out in Tahle No.62, which gives the actual 
figures obtained in a series of cases of scarlet fever.
TABLE No.62.
Disease Age.
' '  — — — " ' ""— ——
Scarlet fever 4
ri w 5
ft ff 6
ft ft 7
ff ff 8
ff ft 9
ff If 11
ff ff 1 2
ft ff 14
If ff 17
ft ft 18
ff If 18
ff ff 19
ff ff 2 0
If ff 2 0
ff ff 2 1
ft ft 2 1
ff ff 2 2
ff If
........- ............... 34
(7)
Height in c.cs. oi column or
erythrocytes at end of one 
_______ hour.___________
7.4
7.4
7.4 
9 
6.2
5
7.5
7.4
7.9
8.5
7.7
6.8 
7.3
6.9
7.8
6
7.7
7.5
9
Frosch bases his conclusion that the temperature 
does not in any way affect the sedimentation time, on 
the comparison of a case of typhoid fever with a 
temperature of 104-105^F and a sedimentation time of 
1.5 hours with a case of acute appendicitis with a 
temperature of lOO^F. and a sedimentation time of 
20/
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20 minutes. A more striking proof of his opinion is 
available in the present series, for by taking say a 
series of 24 cases of erysipelas we can support his 
contention without introducing his fallacy of comparing 
two different types of infection (see Table No.63).
TABIE No.63.
Disease. 'emperature
°F.
ipela 3 98.6
M 99
tt 99
n 99
ff 99.6
If 100
If 100
ff 100
ri lom
ff 101
% 101
ff 101
ft 101
ft 101.4
ff 102
ff 102
ff 102
ff 102
ff 102.2
ff 102.4
ft 102.4
ff 102.8
ff 103.2
ff 104
Height in c.cms. of 
column of erythrocytes 
at end of one hour;
4.5
6.5
4.5 
4
4
4.5 
5.
5.7
3.8
4.2 
4.7
4.9
6.5
6.5
4.2
4.2
4.9
5.2
5.3
7.5 
5
4.5
4.5
4.5
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The figures just quoted for age and temperature 
are sufficiently convincing, but lest it be suggested that 
we have selected two individual groups of cases which 
chance to illustrate the individual points, particularly 
well, we give the details of both age and temperature in 
a single group, viz. acute phthisis (see Tables Nos.
64 and 65.) .
TABLE No.64. TABLE No.65.
Disease. Age. Height in c.cs. 
of column of 
erythrocytes 
at end of 1 hr.
Disease. Temp. Height in c.cs. 
column of 
erythrocytes at 
end of 1 hr.
Acute
phthisis
Yrs
17
17
4i5
5.6
Acute 
phthisis.
97
97.4
5
5
18 5 98 4.1
18 5 98.4 6.5
18 6 98.8 5
19 5 99 4.5
20 4.1 99 5.6
20 6 ' 99.2 3.4
26 6.5 100 6
42 3.4 102 5
It may be added that whereas
(1#
Nees states that
in pulmonary tuberculosis the sedimentation rate is much
(15) (1)
accelerated by a fever, Lorentz and Alexander are of 
opinion that bodily temperature has no such effect.
Turning now to the influence of the type of 
infection on the sedimentation rate, we have the results in 
tabular form (Graph No.59). From these it is obvious 
(1) that the speed of sedimentation is greater in some 
conditions than in others and (2) that the range of 
variation is so great that it is impossible by thés method 
to diagnose or even to suspect the nature of the infection.
Table/
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Table No.66 shows the results obtained from 133 
estimations of the sedimentation of red blood corpuscles 
in various infections.
TABLE No.66.
Condition.
üo.of 
sases.
Variation 
in age.
Range of 
Temp.
Height in ccs. 
of column of 
erythrocytes 
at end of 1 hr.
Mean height 
in ccssof
column of 
erythrocytes 
at end of), h
Normals 26
"^ rs.
9-63
O p
97 - 98 6.1 - 9.2 8.6
Scarlet fever)
after serum %
19 4-34 97 -103 5 - 9 7.4
2 12 98.4-102.8 6 - 7 6.5
Septic scarlet 
fever. 
Toxic do. ) 
)
After serum )
1
1
9
44
100.6
99.8
3.8
5.5
3.8
5.5
Diphtheria 9 6-26 98.4-102. 4 4 - 8.2 6.5
do,after serum 8 8-29 97 -100.2 5 -7.5 6.5
Erysipelas 24 16-62 99-103.2 3.8-7.5 4.6
do.after serum 1 39 98.8 5.4 5.4
Pneumonia 30 12-53 99-103 3.3-7 4.7
Bronchiectasis 1 60 98.4 4.4 4.4
Chronic Bronchi 
tis
Cerebrospinal 
fever 
do. after serum
- 1 
1 
2
39
14
10-15
98.2
100.7
100.4-101.2
5
4.1
5.1
5
4.1
5.1
Encephalitis 
Lethargica. 
Enteric Fever
2
4
29-31
24-43
97-98
97.6-101
6.5-9.2 
3.8-7.5
7.9
5.5
Erysipelas k 
Pneumonia. 
Ileocolitis.
1
1
53
30
102
98.2
7.8
7.8
7.8
7.8
Here we shall leave the general effect of the individual 
infection and pass on to a more detailed consideration of the 
phenomenon of increased sedimentation and its probable cause.
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4. Mode of Production.
(10)
Katz’s experience led him to regard the speed of
sedimentation of the erythrocyte as a sensitive and
reliable index of the destruction of tissue, and dependent
mainly on the amount of fibrinogen in the blood. This
(17) (&&y
view is also held by Zeckwer and Goodell. LBhr
ascribes accelerated sedimentation to excessive destruction
of cells and absorption of product# of destruction.
(15)
Popper and Kreindâer consider that every orgahic
modification affecting the equilibrium of the plasma
reflects in the sedimentation speed the amount of destruction
(13)
of cells going on, while Lorentz is of opinion that
progressively malignant as well as exudative processes
accelerate sedimentation more than innocuous products.
(1)
Alexander is of opinion that the sedimentation rate
is not necessarily due to tuberculosis per se but that
secondary infection of the bronchi is an important factor.
(5)
Cutler maintains that the sedimentation rate reflects the
disturbance produced through absorption of productions
(10) (6) 
of infection. Katz and Frenlowka agree that
acceleration of sedimentation is an index of destruction
of tissue, into which category secondary infection of
the bronchi really falls.
On one point all observers are agreed, viz. that the
determining factor resides in the plasma and not in the
red cells. Thus the washed cells of a pregnant woman
sediment at normal speed in the plasma of a non-pregnant
woman, whereas the cells of the non-pregnant sediment
with undue rapidity in the plasma of a pregnant subject.
The/
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The occurrence of increased speed in sedimentation 
during pregnancy might cast doubt upon the theory that 
tissue destruction is the causal factor, but it must be 
remembered that in early pregnancy the decidua is 
being digested by the villi, and that throughout 
gestation transportation and destruction of villi in 
the blood stream is a constant feature. Incidentally, 
we might mention that the sedimentation test is of 
value in making a specific diagnosis in one condition at 
least, for it is used with much success to differentiate 
an ectopic gestation from an inflammatory mass - the rate 
of sedimentation in extra-uterine gestation being faster 
than in Inflammatory lesions.
Perhaps most light is thrown on the problem by 
a consideration of the phenomenon in patients suffering 
from tuberculous infection. It is apparent in the 
first place from Table No.67 that the speed of sedimentation 
is not dependent merely upon the acuteness or chronicity 
of the disease.
TABLE No.67.
Disease, Height in c.cs. of column of 
at end of 1 hour.
erythrocytes
0 - 4 4 - 8 8 +
Acute Phthisis 17% 83%
Subacute " 54% 46%
Chronic " 19% 75% j 2%
Secondly it is not, as Nees believes, 
proportionate to the patients’ resistance, otherwise the 
rate would be less rapid in subacute than in acute cases.
The results of the present series support the 
view that tissue destruction is an important, if not the 
only causative factor. In ten cases of acute phthisis 
the/
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the average reading was 5 c.cs., while in one acute 
case with pleurisy the reading was 4 c.cs.. Contrast 
with this a case of acute phthisis which was progressing 
well after artificial pneumothorax had been produced - 
the figure here was 6.8 c.cs..
Again in twenty-two cases of chronic phthisis
the average reading was 5.2 c.cs., but in three cases
who were "not doing well", the reading was only 5.9 c.cs..
More striking still is the evidence obtained from the
following cases. One case of chronic phthisis complicated
by tuberculous renal infection gave a reading of 3.5 c.cs.;
a second case similar in character - treated by excision
of the kidney - gave a reading of 9 c.cs.. It is of
(1)
interest to note that Alexander found the sedimentation 
rate normal in two cases of early tuberculous disease of 
the kidney.
Other examples - some not so pronounced - will 
be found in Table No.68.
Finally, it will be apparent that the cases 
quoted corroborate the statement made by Nees, that 
the sedimentation rate runs parallel with the clinical 
condition of the patient.
Table No.68 next page.
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TABLE No.&B.
R ^ u l t 8 obtained from ^  estimations of the 
sedimentation of red blood corpuscles in 
phthisis.
Disease.
Acute Phthisis
do. + Chronic Pleurisy.
do. + Pneumothorax. 
(Doing well)
Subacute Phthisis. 13
Early Phthisis. 1
do. (intermed.) 1
Chronic Phthisis 22
do. (not doing well) 3
Chronic Submcute Phthisis 2
Chronic Phthisis + T.BJfidney 1
do. do. do .excised. 1
do. do. + T.B.knee 1
do. do. + T.B.foot. 1
Pb.of
cases.
10
1
1
Variation 
in age in 
years,
17-42
11
17
11-57
18
20
9-69
17-25
17-18
41
34
18
12
Range
of
Temp.
—
98-102
99
97
97-101
97.6 
98.8 
97-99.8 
97-99
97.4-98
97.4
98.4
97.6
98.4
eight in 
.cs.of red 
blood cells 
at end of 
1 hr.
3.4-6.5
4
6.8
2 * 5—6 *2
5.2
4.4 
3.3-7.5 
5• 1- 4•6 
é 6.8-7.6
3.5 
9
4.5
4.5
Ave.height ir 
c.cs. of red 
blood cells
at edd of 
1 hr.
5
4
6.8
4.4 ;
5.2
4.4
5.2 !
3.9 I
7.2 }'
3.5
I
I
4.5 }
4.5
i.
The cases of phthisis were grouped according to the 
diagnosis made by Dr McGowan from clinical findings. The 
sedimentations were carried out independently.
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5. Conclusions.
1. The method of Zeckwer and Goode&l is easily carried 
out and gives sufficiently accurate results for 
clinical purposes.
2. The average rate of sedimentation in all the
infections studied was definitely below the normal 
average•
3. It was found that the speed of sedimentation of the 
red cells differed in different infections.
4. Nevertheless, it is not possible to make a specific
diagnosis by this method.
5. The phenomenon is not influenced by the age of
the pa tient, nor by the height of the fever per se.
6. It is probable that the rate of sedimentation is 
determined by the amount of tissue destruction.
7. It is certainly not dependent, in cases of
tuberculous infection at least, on the resistance 
of the patient.
, The sedimentation rate varies with the général 
clinical condition, a decrease in the speed of 
sedimentation indicating improvement*
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